Pfizer (PFE) Announces Medivation Acquisition Worth $14 Billion
August 25, 2016
UPDATE: 6:50 a.m. EDT — Pfizer confirmed Monday morning it had “entered a definitive merger agreement” with Medivation to buy the latter “for $81.50 a share in cash for a total enterprise value of approximately $14 billion,” subject to regulatory approvals.